Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-03-29 00:00:00 ET · period of report 2023-03-27 · accession 0001209191-23-021564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-29 | 2023-03-27+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.03 | -13.6K | 528.0K | -3% | -$217.8K |
| DM | 2023-03-29 | 2023-03-27+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +13.6K | 531.3K | +3% | +$8,284 |
| DM | 2023-03-29 | 2023-03-27+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -13.6K | 233.8K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-27 | S | D | 8,048 | $16.00 | 527,981 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-27 | M | A | 8,048 | $0.61 | 536,029 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-28 | S | D | 3,346 | $16.00 | 527,981 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-29 | M | A | 2,187 | $0.61 | 530,168 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-29 | S | D | 2,187 | $16.21 | 527,981 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-28 | M | A | 3,346 | $0.61 | 531,327 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-03-27 | M | D | 8,048 | $0.00 | 239,354 | D | $0.61 · — to 2031-03-09 | 8,048 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-28 | M | D | 3,346 | $0.00 | 236,008 | D | $0.61 · — to 2031-03-09 | 3,346 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-03-29 | M | D | 2,187 | $0.00 | 233,821 | D | $0.61 · — to 2031-03-09 | 2,187 Common Stock | (F2) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |